Annuncio • Jun 30
Luxi Chemical Group Co., Ltd. to Report First Half, 2026 Results on Aug 29, 2026 Luxi Chemical Group Co., Ltd. announced that they will report first half, 2026 results on Aug 29, 2026 Declared Dividend • Jun 25
Dividend reduced to CN¥0.20 Dividend of CN¥0.20 is 43% lower than last year. Ex-date: 26th June 2026 Payment date: 26th June 2026 Dividend yield will be 1.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (41% earnings payout ratio) and cash flows (24% cash payout ratio). The dividend has decreased over the past 86 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 97% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Board Change • May 20
High number of new and inexperienced directors There are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 1 experienced director. 1 highly experienced director. Supervisor Yucai Liu is the most experienced director on the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Annuncio • Apr 29
Luxi Chemical Group Co., Ltd., Annual General Meeting, May 20, 2026 Luxi Chemical Group Co., Ltd., Annual General Meeting, May 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Liaocheng, Shandong China Annuncio • Mar 31
Luxi Chemical Group Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026 Luxi Chemical Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026 Annuncio • Dec 31
Luxi Chemical Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026 Luxi Chemical Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026 Annuncio • Sep 30
Luxi Chemical Group Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Luxi Chemical Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Annuncio • Jul 02
Luxi Chemical Group Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Luxi Chemical Group Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Annuncio • May 27
Luxi Chemical Group Co., Ltd. Approves Dividend for the Year 2024 Luxi Chemical Group Co., Ltd. approved at its AGM held on 23 May 2025 the cash dividend/10 shares (tax included) of CNY 3.50000000 for the year 2024. Annuncio • Apr 26
Luxi Chemical Group Co., Ltd., Annual General Meeting, May 23, 2025 Luxi Chemical Group Co., Ltd., Annual General Meeting, May 23, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Liaocheng, Shandong China Annuncio • Mar 31
Luxi Chemical Group Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Luxi Chemical Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Annuncio • Mar 26
Luxi Chemical Group Co., Ltd. Elects Chen Bifeng as Non-Independent Director Luxi Chemical Group Co., Ltd. held its 2nd Extraordinary General Meeting of 2025 on 24 March 2025, during which the following proposal(s) was/were approved: Election of Chen Bifeng as a non-independent director. Annuncio • Dec 31
Luxi Chemical Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025 Luxi Chemical Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025 Buy Or Sell Opportunity • Nov 08
Now 22% undervalued Over the last 90 days, the stock has risen 12% to CN¥12.22. The fair value is estimated to be CN¥15.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 7.2% over the last 3 years. Earnings per share has declined by 54%. Revenue is forecast to grow by 16% in 2 years. Earnings are forecast to grow by 41% in the next 2 years. Board Change • Oct 11
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 3 experienced directors. 2 highly experienced directors. Employee Supervisor Shu Hai Li is the most experienced director on the board, commencing their role in 2008. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Buy Or Sell Opportunity • Oct 09
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 5.7% to CN¥12.03. The fair value is estimated to be CN¥15.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.3% over the last 3 years. Earnings per share has declined by 52%. Revenue is forecast to grow by 19% in 2 years. Earnings are forecast to grow by 45% in the next 2 years. Annuncio • Sep 30
Luxi Chemical Group Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Luxi Chemical Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥11.52, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 26% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥15.03 per share. Buy Or Sell Opportunity • Jul 01
Now 9.9% undervalued Over the last 90 days, the stock has risen 19% to CN¥12.00. The fair value is estimated to be CN¥13.33, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 37%. Revenue is forecast to grow by 25% in 2 years. Earnings are forecast to grow by 121% in the next 2 years. Annuncio • Jun 29
Luxi Chemical Group Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024 Luxi Chemical Group Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024 Buy Or Sell Opportunity • Jun 19
Now 20% undervalued Over the last 90 days, the stock has risen 20% to CN¥11.84. The fair value is estimated to be CN¥14.85, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 37%. Revenue is forecast to grow by 25% in 2 years. Earnings are forecast to grow by 121% in the next 2 years. Annuncio • May 25
Luxi Chemical Group Co., Ltd. Approves Cash Dividend for the Year 2023 Luxi Chemical Group Co., Ltd. at its AGM held on May 23, 2024, approved cash dividend (tax included) of CNY 1.30000000 per 10 shares for the year 2023. Annuncio • May 02
Luxi Chemical Group Co., Ltd. Proposes Final Cash Dividend for 2023 Luxi Chemical Group Co., Ltd. announced on 30 April 2024 the profit distribution proposal for 2023 as follows: Final Cash dividend/10 shares (tax included): CNY 1.30000000. Annuncio • May 01
Luxi Chemical Group Co., Ltd., Annual General Meeting, May 23, 2024 Luxi Chemical Group Co., Ltd., Annual General Meeting, May 23, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Liaocheng, Shandong China Reported Earnings • Apr 30
First quarter 2024 earnings released: EPS: CN¥0.30 (vs CN¥0.17 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.30 (up from CN¥0.17 in 1Q 2023). Revenue: CN¥6.75b (up 2.6% from 1Q 2023). Net income: CN¥567.9m (up 76% from 1Q 2023). Profit margin: 8.4% (up from 4.9% in 1Q 2023). Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Annuncio • Mar 30
Luxi Chemical Group Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Luxi Chemical Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Annuncio • Dec 29
Luxi Chemical Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024 Luxi Chemical Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024 Reported Earnings • Oct 29
Third quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.19 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.16 (down from CN¥0.19 in 3Q 2022). Revenue: CN¥6.40b (down 6.9% from 3Q 2022). Net income: CN¥312.8m (down 18% from 3Q 2022). Profit margin: 4.9% (down from 5.5% in 3Q 2022). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Annuncio • Sep 30
Luxi Chemical Group Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023 Luxi Chemical Group Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023 New Risk • Aug 29
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 30% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 204% Paying a dividend despite having no free cash flows. Minor Risks High level of debt (81% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.4% net profit margin). Reported Earnings • Aug 29
Second quarter 2023 earnings released: CN¥0.068 loss per share (vs CN¥0.74 profit in 2Q 2022) Second quarter 2023 results: CN¥0.068 loss per share (down from CN¥0.74 profit in 2Q 2022). Revenue: CN¥4.96b (down 45% from 2Q 2022). Net loss: CN¥128.2m (down 109% from profit in 2Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Annuncio • Jul 14
Luxi Chemical Group Co., Ltd. Implements Final Dividend of A Shares for 2022, Payable on 20 July 2023 Luxi Chemical Group Co., Ltd. implemented final cash dividend of CNY 6.50000000 per 10 A shares (tax included) for 2022. Record date is 19 July 2023. Ex-date is 20 July 2023. Payment date is 20 July 2023. Annuncio • Jun 01
Luxi Chemical Group Co., Ltd. Approves Cash Dividend for the Year 2022 Luxi Chemical Group Co., Ltd. held its Annual General Meeting of 2022 on 26 May 2023, approved Cash dividend (tax included) of CNY 6.50000000 per 10 shares. Board Change • Apr 29
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. Independent Director Yun Wang was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Apr 22
First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.69 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.69 in 1Q 2022). Revenue: CN¥6.58b (down 14% from 1Q 2022). Net income: CN¥322.2m (down 76% from 1Q 2022). Profit margin: 4.9% (down from 17% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. Independent Director Yun Wang was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.51 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.19 (down from CN¥0.51 in 3Q 2021). Revenue: CN¥6.87b (down 24% from 3Q 2021). Net income: CN¥380.4m (down 61% from 3Q 2021). Profit margin: 5.5% (down from 11% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: CN¥0.74 (vs CN¥0.86 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.74 (down from CN¥0.86 in 2Q 2021). Revenue: CN¥8.99b (up 8.9% from 2Q 2021). Net income: CN¥1.42b (down 13% from 2Q 2021). Profit margin: 16% (down from 20% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to stay flat compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 16
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥14.70, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 70% over the past three years. Board Change • Jun 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. Independent Director Yun Wang was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Board Change • May 06
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 5 highly experienced directors. Independent Director Yun Wang was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Valuation Update With 7 Day Price Move • Feb 11
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥16.63, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 61% over the past three years. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.51 (vs CN¥0.17 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥9.00b (up 94% from 3Q 2020). Net income: CN¥973.7m (up 299% from 3Q 2020). Profit margin: 11% (up from 5.3% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥20.14, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 58% over the past three years. Valuation Update With 7 Day Price Move • Aug 31
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥22.61, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 68% over the past three years. Reported Earnings • Jul 29
Second quarter 2021 earnings released: EPS CN¥0.86 (vs CN¥0.15 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥8.26b (up 103% from 2Q 2020). Net income: CN¥1.63b (up CN¥1.42b from 2Q 2020). Profit margin: 20% (up from 5.2% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Reported Earnings • Apr 28
First quarter 2021 earnings released: EPS CN¥0.53 (vs CN¥0.01 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥6.22b (up 85% from 1Q 2020). Net income: CN¥999.2m (up CN¥983.9m from 1Q 2020). Profit margin: 16% (up from 0.5% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 24
Full year 2020 earnings released: EPS CN¥0.56 (vs CN¥1.15 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥17.6b (down 2.7% from FY 2019). Net income: CN¥824.8m (down 51% from FY 2019). Profit margin: 4.7% (down from 9.4% in FY 2019). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 20
New 90-day high: CN¥15.76 The company is up 27% from its price of CN¥12.42 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥14.33, the stock is trading at a trailing P/E ratio of 16.3x, up from the previous P/E ratio of 14x. This compares to an average P/E of 35x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 24%. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥12.05, the stock is trading at a trailing P/E ratio of 13.7x, down from the previous P/E ratio of 16.5x. This compares to an average P/E of 36x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 43%. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥15.30, the stock is trading at a trailing P/E ratio of 17.4x, up from the previous P/E ratio of 14.8x. This compares to an average P/E of 35x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 7.2%. Is New 90 Day High Low • Jan 07
New 90-day high: CN¥14.47 The company is up 58% from its price of CN¥9.18 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Dec 05
New 90-day high: CN¥13.25 The company is up 35% from its price of CN¥9.78 on 04 September 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. Is New 90 Day High Low • Nov 10
New 90-day high: CN¥11.62 The company is up 17% from its price of CN¥9.92 on 12 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥1.30b, down 18% from the prior year. Total revenue was CN¥16.5b over the last 12 months, down 14% from the prior year.